Sir Charles Gairdner Hospital in Perth, Australia, and the European CyberKnife Center of Munich, Germany, have joined the Radiosurgery Society (RSS) Registry, a patient registry that determines the use and outcomes of stereotactic radiosurgery and stereotactic body radiotherapy for the treatment of non-cancerous and cancerous lesions. The society now provides data from over 14,000 patients.
One of Australia’s leading teaching tertiary hospitals, Sir Charles Gairdner Hospital provides a comprehensive range of clinical services, including trauma, emergency, and critical care; orthopedics, general medicine, general surgery, and cardiac care. In addition, it is home to West Australia’s only comprehensive cancer center and is the state’s principal hospital for neurosurgery and liver transplants.
The European CyberKnife Center in Munich (ECZM), is recognized for its work with brain and spinal tumors. ECZM is currently the first center worldwide to offer the latest generation CyberKnife M6, providing precision accuracy and shorter treatment times.
RSSearch is a comprehensive database designed to capture screening, treatment, and follow-up data from all stereotactic radiosurgery and stereotactic body radiotherapy-treated lesions throughout the body. After these recent additions to the RSS, the RSSearch is now one of the largest international databases of its kind, providing data from over 14,000 patients with benign and malignant lesions, including brain and spinal tumors and cancers of the lung, prostate, pancreas and liver, all of whom were treated with stereotactic radiosurgery and stereotactic body radiotherapy.
RSS ultimately aims to collect information on treatment management practices of stereotactic radiosurgery and stereotactic body radiotherapy, in order to report on clinical outcomes, including treatment effectiveness and quality of care for patients, as well as to contribute to the creation of patient care guidelines.